Brean Murray Carret & Co. Reiterates Hold On Steris Corp. (STE)
Brean Murray Carret & Co. released a research report reiterating its Hold rating on shares of Steris Corp. (NYSE: STE) today. According to the report, "our interactions with customers, company reps, and senior management reinforce our view that in the long run there remains plenty of risk in the stock. However, we believe the near-term outcomes may be less worrisome than we had previously thought. We are incrementally positive about the March quarter, but lingering risks keep us from advocating long-term positions in the stock."
During today's trading session, Steris Corp. (STE) has lost 0.52% to $32.82. Steris Corporation (STE), together with its subsidiaries, develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers worldwide.
